Products

Online Inquiry

As a CRO specializing in cardiovascular disease research, Ace Therapeutics offers a range of inhibitors & activators to study and understand the mechanisms underlying various cardiovascular conditions. These compounds play a crucial role in drug discovery and the development of potential therapies.

Inhibitors & Activators

Azelnidipine-d7 (CDIA-2066) Inquiry
Formula:
C33H27D7N4O6
Molecular Weight:
589.69

Rivaroxaban-d4 (CDIA-2067) Inquiry
Formula:
C19H14D4ClN3O5S
CAS Number:
1132681-38-9
Molecular Weight:
439.91

Sugammadex (CDIA-2068) Inquiry
Formula:
C72H112O48S8
CAS Number:
343306-71-8
Molecular Weight:
2002.15

Doxazosin-d8 (CDIA-2070) Inquiry
Formula:
C23H17D8N5O5
CAS Number:
1126848-44-9
Molecular Weight:
459.52

Ivabradine-d6 (CDIA-2071) Inquiry
Formula:
C27H30D6N2O5
Molecular Weight:
474.62

Regadenoson-d3 (CDIA-2072) Inquiry
Formula:
C15H15D3N8O5
Molecular Weight:
393.37

Metolazone-d7 (CDIA-2073) Inquiry
Formula:
C16H9D7ClN3O3S
CAS Number:
2714484-71-4
Molecular Weight:
372.88

Tranexamic acid-d2 (CDIA-2074) Inquiry
Formula:
C8H13D2NO2
Molecular Weight:
159.22

Methacholine bromide (CDIA-2075) Inquiry
Formula:
C8H18BrNO2
CAS Number:
333-31-3
Molecular Weight:
240.14

Trandolaprilate hydrate (CDIA-2076) Inquiry
Formula:
C22H32N2O6
CAS Number:
951393-55-8
Molecular Weight:
420.50

! For research use only. Not intended for any clinical use.